CYMBALTA

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Netherlands, Poland, Romania, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug CYMBALTA contains one active pharmaceutical ingredient (API):

1	Duloxetine UNII 9044SC542W - DULOXETINE HYDROCHLORIDE
	Duloxetine is a combined serotonin (5-HT) and noradrenaline (NA) reuptake inhibitor. It weakly inhibits dopamine reuptake with no significant affinity for histaminergic, dopaminergic, cholinergic and adrenergic receptors.
	Read more about Duloxetine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CYMBALTA Hard gastro-resistant capsule	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06AX21	Duloxetine	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AX Other antidepressants
Discover more medicines within N06AX21

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	9155W, 9156X
BR	Câmara de Regulação do Mercado de Medicamentos	507603304116210, 507603306119314, 507603308111310, 507603310116316, 507612050017103, 507612050017203, 507614060018003, 507620020020607
CA	Health Products and Food Branch	02301482, 02301490
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00104484, 00203559, 00203565, 00203588, 00225325, 00348513, 00363352, 00403531, 00403548, 00429200, 00565009, 00770531, 00770548, 00834159, 00896769, 00896781, 01097007, 01138829, 01852857, 02187669, 02579010, 02582791, 02844423, 03426969, 03427041, 03882503, 04049121, 04165436, 04165442, 04165459, 04866423, 04957611, 04957628, 04965237, 05124511, 05500546, 05500569, 06152254, 06439033, 06439056, 07023990, 07177339, 07355893, 09224008, 09224020, 09241283, 10005234, 10005263, 12502988, 13883840, 14139894, 14139902, 14281474, 15612447, 15612453
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	30266-07-12, 30291-09-12
EE	Ravimiamet	1195624, 1195635, 1207639, 1207662, 1207673, 1207684, 1286007, 1286018, 1363665
ES	Centro de información online de medicamentos de la AEMPS	04296001, 04296001IP, 04296002, 04296002IP, 04296002IP1, 04296002IP2, 04296002IP3, 04296002IP4, 04296006
FI	Lääkealan turvallisuus- ja kehittämiskeskus	021721, 021967
FR	Base de données publique des médicaments	66852477, 68263545
GB	Medicines & Healthcare Products Regulatory Agency	138590, 138592, 374339, 374341, 90387, 90394
HK	Department of Health Drug Office	53843, 53844
IE	Health Products Regulatory Authority	19961, 19975, 19990, 19995, 21006, 21010
IL	מִשְׂרַד הַבְּרִיאוּת	4823, 4824
IT	Agenzia del Farmaco	036683011, 036683023, 036683062, 047516012
JP	医薬品医療機器総合機構	1179052M1022, 1179052M2029
LT	Valstybinė vaistų kontrolės tarnyba	1004485, 1004486, 1028355, 1028356, 1028357, 1028358, 1028359, 1028360, 1028361
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	211M2004
NL	Z-Index G-Standaard, PRK	79057, 79065
PL	Rejestru Produktów Leczniczych	100145563, 100145570
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W43297001, W43297002, W43297003, W43298001, W43298002, W43298003, W43298004, W43298005, W43298006
SG	Health Sciences Authority	13189P, 13190P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699673170206, 8699673170213
US	FDA, National Drug Code	0002-3235, 0002-3240, 0002-3270, 55289-028, 55289-036, 70518-2099
ZA	Health Products Regulatory Authority	37/1.2/0299, 37/1.2/0301